Quantum Market Cap
QSI

Quantum-Si

QSIQuantum Biology
$0.9990โ–ฒ+5.79%(+$0.0547)
1W โ–ฒ+5.52%1M โ–ฒ+0.91%1Y โ–ผ-42.25%
Price History
Compare vs
Jun 12Jun 15Jun 16Jun 17Jun 18Jun 20$0.93$0.96$0.99$1.04
Key Statistics

Market Capโ“˜

$217.54M

Cash Runwayโ“˜

24 mo

52W Highโ“˜

$3.10

52W Lowโ“˜

$0.6912

2Y Highโ“˜

$25.00

-96.0% below 2Y high

RSI (14-day)โ“˜

48.6

Neutral

Beta (1Y vs SPY)โ“˜

1.31

Above Market

Next Earningsโ“˜

Aug 3, 2026

in 44 days

Daily Short Vol %โ“˜

50.1%

2026-06-18

About Quantum-Si

Quantum-Si is building a semiconductor chip-based platform for single-molecule protein sequencing using quantum-detection technology. Its Platinum Pro system targets proteomics research; next-gen Proteus instrument targets late 2026 commercial launch.

Sector

Life Sciences Tools & Services

Industry

Life Sciences Tools & Services

Founded

2017

Headquarters

Guilford, CT

Shares Outstanding

217.8M

Quantum Division

https://www.quantum-si.com/technology/

Visit โ†—

Quantum Technology

Roadmap Target

Proteus commercial launch late 2026 (18+ amino acids, ~1,000ร— throughput); 20 of 20 amino acids by 2027

Quantum-Si is NOT a quantum computing company. It uses quantum tunneling detection in a CMOS semiconductor chip for single-molecule protein sequencing (proteomics). Current product: Platinum Pro (launched Jan 2025, V4 kit detects 17 of 20 amino acids). Next-gen: Proteus instrument (late 2026 commercial launch target) โ€” 18+ amino acids at launch, tens of millions of peptides per experiment (vs. tens of thousands on Platinum Pro), ~90 min run time. Successful sequencing on integrated Proteus instruments (April 2026, KinetIQ Array dev kit, 17 amino acids); Early Access Program summer 2026.

Quantum Sector Market Cap Share

0.3% of sector
IONQ$21.10B31.4%
QNT$18.20B27.1%
QBTS$9.14B13.6%
RGTI$7.10B10.6%
XNDU$3.98B5.9%
INFQ$2.95B4.4%
QUBT$2.43B3.6%
HQ$1.65B2.5%
ARQQ$414M0.6%
QSI$218M0.3%

Analyst Price Targets

3 analysts

Low Target

$1.00

+0.1%

Median Target

$2.50

+150.3%

High Target

$4.00

+300.4%

$1.00 low+150.3% to mean$4.00 high

Analyst Recommendations

Buy (2)Hold (1)

Recommendation Trend

PeriodStrong BuyBuyHoldSellStrong SellTotal
Current021003
1 mo ago021003
2 mo ago021003

Current Ratings by Analyst (3 firms)

HC Wainwright & Co.Buy
reiterated2025-05-19
Alliance Global PartnersBuy
initiated2025-02-07
Canaccord GenuityHold
reiterated2026-03-05

Source: Finnhub ยท most recent rating per firm

Consensus Target History

05/0605/0705/1105/1205/1305/1505/1605/2705/2805/2905/3006/0406/0506/0606/0706/0906/1006/1106/1206/1306/1606/1706/1806/1906/20$0.00$2.00$5Price

Solid = mean ยท dashed = high/low range ยท horizontal line = current price